tiprankstipranks
Advertisement
Advertisement
Capricor Therapeutics call volume above normal and directionally bullish
PremiumThe FlyCapricor Therapeutics call volume above normal and directionally bullish
13d ago
Capricor Therapeutics upgraded to Outperform from Perform at Oppenheimer
Premium
The Fly
Capricor Therapeutics upgraded to Outperform from Perform at Oppenheimer
13d ago
Midday Fly By: Nvidia warns of price hikes, nVent to acquire Maverick Power
Premium
The Fly
Midday Fly By: Nvidia warns of price hikes, nVent to acquire Maverick Power
14d ago
Capricor says FDA extends action date for Deramiocel for amendment review
PremiumThe FlyCapricor says FDA extends action date for Deramiocel for amendment review
14d ago
Capricor Therapeutics jumps 18% to $7.42 as FDA reviews Deramiocel
Premium
The Fly
Capricor Therapeutics jumps 18% to $7.42 as FDA reviews Deramiocel
14d ago
Kaos Capital urges Capricor shareholders to support immediate board meeting
Premium
The Fly
Kaos Capital urges Capricor shareholders to support immediate board meeting
17d ago
Capricor Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
PremiumThe FlyCapricor Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
22d ago
Cantor upgrades Capricor on ‘major update’ from earnings call
Premium
The Fly
Cantor upgrades Capricor on ‘major update’ from earnings call
22d ago
Capricor Therapeutics: FDA ‘willing’ to review BLA amendment, extend PDUFA date
Premium
The Fly
Capricor Therapeutics: FDA ‘willing’ to review BLA amendment, extend PDUFA date
22d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100